Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease

Peptides and their mimetics are increasingly recognised as drug-like molecules, particularly for intracellular protein-protein interactions too large for inhibition by small molecules, and inaccessible to larger biologics. In the past two decades, evidence associating the misfolding and aggregation...

Descripción completa

Detalles Bibliográficos
Autores principales: Allen, Scott G., Meade, Richard M., White Stenner, Lucy L., Mason, Jody M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633918/
https://www.ncbi.nlm.nih.gov/pubmed/37940962
http://dx.doi.org/10.1186/s13024-023-00675-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633918/
https://www.ncbi.nlm.nih.gov/pubmed/37940962
http://dx.doi.org/10.1186/s13024-023-00675-8

Ejemplares similares